Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Adapalene and Clindamycin Hydrochloride Gel in Acne
NCT02593383Phase 2Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Mar 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of adapalene + clindamycin in acne vulgaris (5 arms), sponsored by Lee's Pharmaceutical Holdings Limited. Primary endpoint: Efficacy Endpoint at 12 weeks. Started Mar 2015; status: completed.
02
Drugs
adapalene + clindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02593383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02593383.